Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian Association for the Study of the Pancreas

World J Gastroenterol. 2013 Nov 28;19(44):7930-46. doi: 10.3748/wjg.v19.i44.7930.

Abstract

This is a medical position statement developed by the Exocrine Pancreatic Insufficiency collaborative group which is a part of the Italian Association for the Study of the Pancreas (AISP). We covered the main diseases associated with exocrine pancreatic insufficiency (EPI) which are of common interest to internists/gastroenterologists, oncologists and surgeons, fully aware that EPI may also occur together with many other diseases, but less frequently. A preliminary manuscript based on an extended literature search (Medline/PubMed, Cochrane Library and Google Scholar) of published reports was prepared, and key recommendations were proposed. The evidence was discussed at a dedicated meeting in Bologna during the National Meeting of the Association in October 2012. Each of the proposed recommendations and algorithms was discussed and an initial consensus was reached. The final draft of the manuscript was then sent to the AISP Council for approval and/or modification. All concerned parties approved the final version of the manuscript in June 2013.

Keywords: Chronic pancreatitis; Clinical studies; Exocrine pancreatic insufficiency; Gastric surgery; Pancreatic neoplasms; Pancreatic surgery; Risk factors.

Publication types

  • Practice Guideline
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adult
  • Age Factors
  • Algorithms
  • Critical Pathways / standards
  • Endocrinology / standards*
  • Enzyme Replacement Therapy / standards
  • Exocrine Pancreatic Insufficiency / diagnosis*
  • Exocrine Pancreatic Insufficiency / etiology
  • Exocrine Pancreatic Insufficiency / physiopathology
  • Exocrine Pancreatic Insufficiency / therapy*
  • Gastrointestinal Agents / therapeutic use
  • Humans
  • Nutrition Therapy / standards
  • Pancreatic Function Tests / standards
  • Predictive Value of Tests
  • Risk Factors
  • Societies, Medical / standards*
  • Treatment Outcome

Substances

  • Gastrointestinal Agents